164 studies found for:    "Wilms tumor"
Show Display Options
Rank Status Study
21 Withdrawn RO4929097 in Children With Relapsed/Refractory Solid or CNS Tumors, Lymphoma, or T-Cell Leukemia
Conditions: Lymphoma;   Brain Neoplasms;   Sarcoma;   Osteosarcoma;   Wilm's Tumor
Interventions: Drug: RO4929097;   Drug: Dexamethasone
22 Unknown  Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric Patients
Conditions: Neuroblastoma;   Rhabdomyosarcoma;   Lymphoma;   Wilm's Tumor;   Ewing's Sarcoma
Intervention: Drug: Recombinant Vaccinia GM-CSF; RAC VAC GM-CSF (JX-594)
23 Recruiting Characterization of WAGR Syndrome and Other Chromosome 11 Gene Deletions
Conditions: WAGR Syndrome;   Wilm's Tumor;   Aniridia;   Urogenital Abnormalities;   Mental Retardation
Intervention:
24 Unknown  Chemotherapy Before and After Surgery in Treating Children With Wilm's Tumor
Condition: Kidney Cancer
Interventions: Biological: dactinomycin;   Drug: carboplatin;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: vincristine sulfate;   Procedure: adjuvant therapy;   Procedure: conventional surgery;   Procedure: neoadjuvant therapy;   Radiation: radiation therapy
25 Unknown  Studying Biomarkers in Samples From Younger Patients With Wilms Tumor
Condition: Kidney Cancer
Interventions: Genetic: gene expression analysis;   Genetic: proteomic profiling;   Genetic: reverse transcriptase-polymerase chain reaction;   Genetic: western blotting;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Procedure: spectroscopy
26 Unknown  Biomarkers in Urine Samples From Patients With Wilms Tumor
Condition: Kidney Cancer
Interventions: Genetic: proteomic profiling;   Other: enzyme-linked immunosorbent assay;   Other: laboratory biomarker analysis;   Other: medical chart review
27 Unknown  Biomarkers in Blood and Tumor Tissue Samples From Patients With Wilms Tumor
Conditions: Kidney Cancer;   Renal Failure
Interventions: Genetic: mutation analysis;   Genetic: polymerase chain reaction;   Other: laboratory biomarker analysis
28 Unknown  DNA Variations in the Gene in Young Patients With Wilms' Tumor
Condition: Kidney Cancer
Interventions: Genetic: molecular genetic technique;   Genetic: polymerase chain reaction;   Genetic: polymorphism analysis
29 Completed
Has Results
Wilm's Tumor 1 (WT1) Peptide Vaccine for High Risk Hematologic Malignancy
Conditions: Myelodysplastic Syndrome;   Acute Myeloid Leukemia (AML);   Chronic Myeloid Leukemia (CML)
Intervention: Drug: WT1 Peptide Vaccine
30 Unknown  Biomarkers in Tumor Tissue Samples From Young Patients With Very Low Risk Wilms Tumors
Condition: Kidney Cancer
Interventions: Genetic: DNA methylation analysis;   Genetic: gene expression analysis;   Genetic: loss of heterozygosity analysis;   Genetic: microarray analysis;   Genetic: mutation analysis;   Genetic: polymerase chain reaction;   Genetic: reverse transcriptase-polymerase chain reaction;   Other: laboratory biomarker analysis
31 Unknown  WT1 Peptid Vaccination in Carcinomas
Condition: WT1 Expressing Carcinoma
Intervention: Biological: WT1 126-134 peptide
32 Unknown  Studying Biomarkers in Urine Samples From Younger Patients With Wilms Tumor
Condition: Kidney Cancer
Interventions: Other: laboratory biomarker analysis;   Other: metabolic assessment;   Other: specimen magnetic resonance imaging;   Procedure: spectroscopy
33 Unknown  Studying Biomarkers in Samples From Younger Patients With Wilms Tumor
Condition: Kidney Cancer
Interventions: Genetic: DNA analysis;   Genetic: nucleic acid amplification;   Other: diagnostic laboratory biomarker analysis;   Other: medical chart review
34 Unknown  Biomarkers in Samples From Younger Patients With Wilms Tumor
Condition: Kidney Cancer
Interventions: Genetic: microarray analysis;   Other: laboratory biomarker analysis;   Other: medical chart review
35 Unknown  Chemotherapy Followed by Surgery and Radiation Therapy With or Without Stem Cell Transplant in Treating Patients With Relapsed or Refractory Wilms' Tumor or Clear Cell Sarcoma of the Kidney
Condition: Kidney Cancer
Interventions: Biological: dactinomycin;   Drug: carboplatin;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: melphalan;   Drug: vincristine sulfate;   Procedure: autologous bone marrow transplantation;   Procedure: conventional surgery;   Procedure: peripheral blood stem cell transplantation;   Radiation: radiation therapy
36 Recruiting Anti-Angiogenic Therapy Post Transplant (ASCR) for Relapsed and Refractory Pediatric Solid Tumors
Conditions: Glioma;   Neuroectodermal Tumors, Primitive;   Wilms Tumor;   Rhabdomyosarcoma;   Sarcoma, Ewing;   Osteosarcoma;   Retinoblastoma
Interventions: Drug: Metronomic Cyclophosphamide;   Drug: Thalidomide
37 Completed Pharmacokinetic Study of Doxorubicin in Children With Cancer
Conditions: Wilms Tumor;   Neuroblastoma;   Soft Tissue Sarcoma;   Acute Lymphoblastic Leukemia
Intervention: Drug: doxorubicin
38 Completed Chemotherapy With CD133+ Select Autologous Hematopoietic Stem Cells for Children With Solid Tumors and Lymphomas
Conditions: Neuroblastoma;   Central Nervous System Tumors;   Lymphomas;   Wilms Tumor
Interventions: Procedure: Stem Cell Transplantation;   Drug: Busulfan, Melphalan
39 Active, not recruiting iCAT for Recurrent/Refractory/HR Solid Tumors
Conditions: Pediatric Solid Tumor;   Sarcoma;   Neuroblastoma;   Wilms Tumor
Intervention:
40 Completed
Has Results
Study of High-Dose Chemotherapy With Bone Marrow or Stem Cell Transplant for Rare Poor-Prognosis Cancers
Conditions: Wilms Tumor;   Fibrosarcoma;   Carcinoma, Round Cell;   Nasopharyngeal Cancer;   Brain Tumor, Recurrent
Interventions: Procedure: Myeloablative Chemotherapy;   Procedure: Stem Cell Rescue

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years